Towerpoint Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.46M Buy
4,549
+267
+6% +$273K 1.89% 12
2026
Q1
$3.94M Sell
4,282
-1
-0% -$1.01K 1.59% 14
2025
Q4
$4.6M Sell
4,283
-9
-0.2% -$8.61K 1.82% 12
2025
Q3
$3.27M Buy
4,292
+26
+0.6% +$19.3K 1.34% 20
2025
Q2
$3.33M Buy
4,266
+3
+0.1% +$2.33K 1.47% 17
2025
Q1
$3.52M Sell
4,263
-11
-0.3% -$9.15K 1.75% 13
2024
Q4
$3.3M Sell
4,274
-1
-0% -$828 1.62% 18
2024
Q3
$3.79M Sell
4,275
-3
-0.1% -$2.7K 1.79% 16
2024
Q2
$3.87M Buy
4,278
+14
+0.3% +$11.2K 1.93% 16
2024
Q1
$3.32M Buy
4,264
+38
+0.9% +$27K 1.67% 17
2023
Q4
$2.46M Sell
4,226
-11
-0.3% -$6.42K 1.34% 20
2023
Q3
$2.28M Sell
4,237
-2
-0% -$1.03K 1.35% 20
2023
Q2
$1.99M Buy
4,239
+22
+0.5% +$9.23K 1.12% 21
2023
Q1
$1.45M Sell
4,217
-3,523
-46% -$1.19M 0.83% 23
2022
Q4
$2.83M Buy
7,740
+31
+0.4% +$11K 1.63% 16
2022
Q3
$2.49M Buy
7,709
+12
+0.2% +$3.8K 1.5% 17
2022
Q2
$2.5M Buy
7,697
+96
+1% +$28.8K 1.49% 17
2022
Q1
$2.18M Sell
7,601
-74
-1% -$19K 1.08% 24
2021
Q4
$2.12M Buy
7,675
+100
+1% +$25.4K 1% 26
2021
Q3
$1.75M Sell
7,575
-18
-0.2% -$4.44K 0.87% 25
2021
Q2
$1.74M Sell
7,593
-96
-1% -$19.3K 0.87% 27
2021
Q1
$1.44M Buy
7,689
+4,056
+112% +$793K 0.69% 26
2020
Q4
$613K Sell
3,633
-79
-2% -$11.8K 0.31% 36
2020
Q3
$549K Buy
3,712
+96
+3% +$14.9K 0.31% 35
2020
Q2
$594K Buy
3,616
+26
+0.7% +$3.99K 0.37% 33
2020
Q1
$498K Buy
3,590
+15
+0.4% +$2.06K 0.39% 31
2019
Q4
$470K Hold
3,575
0.31% 32
2019
Q3
$400K Hold
3,575
0.27% 32
2019
Q2
$389K Hold
3,575
0.27% 34
2019
Q1
$464K Buy
+3,575
New +$435K 0.32% 28

Other funds holding LLY

Towerpoint Wealth's LLY Position: Q2 2026 in Review

Towerpoint Wealth increased its Eli Lilly (LLY) stake by 6.2% in Q2 2026, buying an estimated $273K and bringing the position to 4,549 shares worth $5.46M. The position accounts for 1.89% of the portfolio, ranked #12.

Towerpoint Wealth first reported a position in LLY in Q1 2019 and has held it in 30 quarters since. 1,815 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Towerpoint Wealth held 4,549 shares of Eli Lilly worth $5.46M as of Q2 2026.
  • Towerpoint Wealth bought 267 Eli Lilly shares in Q2 2026, an estimated $273K.
  • Eli Lilly made up 1.89% of Towerpoint Wealth's portfolio in Q2 2026, its #12 holding.
  • Towerpoint Wealth first reported a position in Eli Lilly in Q1 2019 and has held it in 30 quarters since.
  • 1,815 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Towerpoint Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.